- Home
- AMPH vs GOF Comparison
AMPH vs GOF Comparison
Compare AMPH & GOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPH
- GOF
- Stock Information
- Founded
- AMPH 1996
- GOF 2006
- Country
- AMPH United States
- GOF United States
- Employees
- AMPH N/A
- GOF N/A
- Industry
- AMPH Biotechnology: Pharmaceutical Preparations
- GOF Finance/Investors Services
- Sector
- AMPH Health Care
- GOF Finance
- Exchange
- AMPH Nasdaq
- GOF Nasdaq
- Market Cap
- AMPH 2.5B
- GOF 2.3B
- IPO Year
- AMPH 2014
- GOF N/A
- Fundamental
- Price
- AMPH $44.55
- GOF $15.82
- Analyst Decision
- AMPH Buy
- GOF
- Analyst Count
- AMPH 4
- GOF 0
- Target Price
- AMPH $63.00
- GOF N/A
- AVG Volume (30 Days)
- AMPH 404.9K
- GOF 789.2K
- Earning Date
- AMPH 11-06-2024
- GOF 01-01-0001
- Dividend Yield
- AMPH N/A
- GOF 15.42%
- EPS Growth
- AMPH 17.38
- GOF N/A
- EPS
- AMPH 3.01
- GOF N/A
- Revenue
- AMPH $723,549,000.00
- GOF N/A
- Revenue This Year
- AMPH $17.23
- GOF N/A
- Revenue Next Year
- AMPH $10.25
- GOF N/A
- P/E Ratio
- AMPH $14.78
- GOF N/A
- Revenue Growth
- AMPH 20.33
- GOF N/A
- 52 Week Low
- AMPH $36.56
- GOF $10.96
- 52 Week High
- AMPH $65.92
- GOF $16.76
- Technical
- Relative Strength Index (RSI)
- AMPH 38.65
- GOF 52.51
- Support Level
- AMPH $43.09
- GOF $15.57
- Resistance Level
- AMPH $49.53
- GOF $15.75
- Average True Range (ATR)
- AMPH 1.76
- GOF 0.13
- MACD
- AMPH -0.62
- GOF -0.02
- Stochastic Oscillator
- AMPH 13.43
- GOF 49.04
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
About GOF Guggenheim Strategic Opportunities Fund of Beneficial Interest
Guggenheim Strategic Opportunities Fund is a diversified, closed-end management investment company. The investment objective of the firm is to maximize total return through a combination of current income and capital appreciation. The Fund seeks to combine a credit-managed fixed-income portfolio with access to a diversified pool of alternative investments and equity strategies.